Héroux Madeleine, Breton Billy, Hogue Mireille, Bouvier Michel
Département de Biochimie, Institut de Recherche en Immunologie et Cancérologie and Groupe de Recherche Universitaire sur le Médicament, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, QC, Canada H3C 3J7.
Biochemistry. 2007 Jun 12;46(23):7022-33. doi: 10.1021/bi0622470. Epub 2007 May 16.
Biochemical and functional evidence suggest that the calcitonin receptor-like receptor (CRLR) interacts with receptor activity-modifying protein-1 (RAMP1) to generate a calcitonin gene-related peptide (CGRP) receptor. Using bioluminescence resonance energy transfer (BRET), we investigated the oligomeric assembly of the CRLR-RAMP1 signaling complex in living cells. As for their wild-type counterparts, fusion proteins linking CRLR and RAMP1 to the energy donor Renilla luciferase (Rluc) and energy acceptor green fluorescent protein (GFP) reach the cell surface only upon coexpression of CRLR and RAMP1. Radioligand binding and cAMP production assays also confirmed that the fusion proteins retained normal functional properties. BRET titration experiments revealed that CRLR and RAMP1 associate selectively to form heterodimers. This association was preserved for a mutated RAMP1 that cannot reach the cell surface, even in the presence of CRLR, indicating that the deficient targeting resulted from the altered conformation of the complex rather than a lack of heterodimerization. BRET analysis also showed that, in addition to associate with one another, both CRLR and RAMP1 can form homodimers. The homodimerization of the coreceptor was further confirmed by the ability of RAMP1 to prevent cell surface targeting of a truncated RAMP1 that normally exhibits receptor-independent plasma membrane delivery. Although the role of such dimerization remains unknown, BRET experiments clearly demonstrated that CRLR can engage signaling partners, such as G proteins and beta-arrestin, following CGRP stimulation, only in the presence of RAMP1. In addition to shed new light on the CRLR-RAMP1 signaling complex, the BRET assays developed herein offer new biosensors for probing CGRP receptor activity.
生化和功能证据表明,降钙素受体样受体(CRLR)与受体活性修饰蛋白-1(RAMP1)相互作用,生成降钙素基因相关肽(CGRP)受体。我们利用生物发光共振能量转移(BRET)技术,研究了活细胞中CRLR-RAMP1信号复合物的寡聚组装情况。与野生型对应物一样,将CRLR和RAMP1与能量供体海肾荧光素酶(Rluc)和能量受体绿色荧光蛋白(GFP)连接的融合蛋白,只有在CRLR和RAMP1共表达时才能到达细胞表面。放射性配体结合和cAMP生成试验也证实,融合蛋白保留了正常的功能特性。BRET滴定实验表明,CRLR和RAMP1选择性结合形成异二聚体。即使在存在CRLR的情况下,这种结合对于无法到达细胞表面的突变型RAMP1也得以保留,这表明靶向缺陷是由复合物构象改变导致的,而非缺乏异二聚化。BRET分析还表明,除了彼此结合外,CRLR和RAMP1都能形成同二聚体。RAMP1能够阻止通常表现出不依赖受体的质膜递送的截短型RAMP1靶向细胞表面,这进一步证实了共受体的同二聚化。尽管这种二聚化的作用尚不清楚,但BRET实验清楚地表明,只有在存在RAMP1的情况下,CGRP刺激后CRLR才能与信号转导伙伴(如G蛋白和β-抑制蛋白)结合。除了为CRLR-RAMP1信号复合物提供新的见解外,本文开发的BRET检测方法还为探测CGRP受体活性提供了新的生物传感器。